Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil
(D00407)		[3] Methylprednisolone,
Mycophenolate mofetil,
Prednisone		[5] Methylprednisolone (D00407),
Prednisone ,
Mycophenolate mofetil ,
Methylprednisolone acetate ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 49 💬
2Administration of methylprednisolone, paracetamol and dexchlorpheniramine
(D00407)		[2] Dexchlorpheniramine,
Methylprednisolone		[3] Methylprednisolone (D00407),
Methylprednisolone acetate ,
Dexchlorpheniramine 💬 		[2] HRH1,
NR3C1 💬 		[4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 49 💬
3Administration of rituximab and methylprednisolone
(D00407)		[2] Methylprednisolone,
Rituximab		[3] Methylprednisolone (D00407),
Methylprednisolone acetate ,
Rituximab 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 51 💬
4Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
(D00407)		[4] Imipenem,
Meropenem,
Methylprednisolone,
Ursodeoxycholic acid		[7] Imipenem ,
Methylprednisolone (D00407),
Ursodiol ,
Methylprednisolone acetate ,
Meropenem ,
Imipenem ,
Meropenem 💬 		[2] NR1H4,
NR3C1 💬 		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 296 💬
5Corticosteroid treatment (Methylprednisolone or prednisolone)
(D00407)		[2] Methylprednisolone,
Prednisolone		[3] Methylprednisolone (D00407),
Prednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 64 💬
6Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
(D00407)		[4] Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		[7] Azathioprine ,
Cyclophosphamide ,
Methylprednisolone (D00407),
Prednisone ,
Methylprednisolone acetate ,
Azathioprine sodium ,
Cyclophosphamide 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
7High-dose intravenous methylprednisolone
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
8Infliximab, methylprednisolone, methotrexate
(D00407)		[3] Infliximab,
Methotrexate,
Methylprednisolone		[5] Methotrexate ,
Methylprednisolone (D00407),
Methylprednisolone acetate ,
Methotrexate sodium ,
Infliximab 💬 		[4] DHFR,
DHFR2,
NR3C1,
TNF 💬 		[70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
9Interferon-beta-1a (Avonex) plus methylprednisolone
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
10Intravenous (i.v.) methylprednisolone 1000 mg, total 9
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 222, 223 💬
11Intravenous Methylprednisolone
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 13, 97, 145 💬
12Intravenous Methylprednisolone (IVMP)
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
13Intravenous methylprednisolone (IVMP) and Efgartigimod
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
14IV methylprednisolone
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
15IV methylprednisolone (steroids)
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
16Megadose oral methylprednisolone
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
17Methotrexate + Methylprednisolone
(D00407)		[2] Methotrexate,
Methylprednisolone		[4] Methotrexate ,
Methylprednisolone (D00407),
Methylprednisolone acetate ,
Methotrexate sodium 💬 		[3] DHFR,
DHFR2,
NR3C1 💬 		[4] Folate biosynthesis, Folate transport and metabolism, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬[1] 46 💬
18Methylprednisolone
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[51] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
19Methylprednisolone (Corticosteroid)
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
20Methylprednisolone (drug)
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 66 💬
21Methylprednisolone (MP)
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 60, 65, 285 💬
22Methylprednisolone (MP) or prednisone (pred)
(D00407)		[2] Methylprednisolone,
Prednisone		[3] Methylprednisolone (D00407),
Prednisone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
23Methylprednisolone (or other glucocorticoid)
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
24Methylprednisolone (Solu-Medrol)
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 14 💬
25Methylprednisolone 1250 mg/24h x3 days
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
26METHYLPREDNISOLONE ACETATE
(D00407)		[2] Acetate,
Methylprednisolone		[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 46, 51 💬
27Methylprednisolone and azathioprine
(D00407)		[2] Azathioprine,
Methylprednisolone		[4] Azathioprine ,
Methylprednisolone (D00407),
Methylprednisolone acetate ,
Azathioprine sodium 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 93, 95 💬
28Methylprednisolone and IVIG
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
29Methylprednisolone and Mycophenolate mofetil
(D00407)		[2] Methylprednisolone,
Mycophenolate mofetil		[4] Methylprednisolone (D00407),
Mycophenolate mofetil ,
Methylprednisolone acetate ,
Mycophenolate mofetil hydrochloride 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[2] 93, 95 💬
30Methylprednisolone bolus IV 15 mg/kg/d for 3 days.
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
31Methylprednisolone hemisuccinate
(D00407)		[2] Methylprednisolone,
Methylprednisolone hemisuccinate		[4] Methylprednisolone (D00407),
Methylprednisolone sodium succinate ,
Methylprednisolone acetate ,
Methylprednisolone hemisuccinate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 85 💬
32Methylprednisolone IV
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
33METHYLPREDNISOLONE MYLAN Générique
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
34Methylprednisolone or budesonide
(D00407)		[2] Budesonide,
Methylprednisolone		[3] Budesonide ,
Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
35Methylprednisolone or Prednisolone
(D00407)		[2] Methylprednisolone,
Prednisolone		[3] Methylprednisolone (D00407),
Prednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
36Methylprednisolone PO
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
37Methylprednisolone pulse
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
38Methylprednisolone pulses plus prednisone versus Cyclosporine A
(D00407)		[3] Cyclosporine,
Methylprednisolone,
Prednisone		[4] Cyclosporine ,
Methylprednisolone (D00407),
Prednisone ,
Methylprednisolone acetate 💬 		[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 223 💬
39METHYLPREDNISOLONE SODIUM HEMISUCCINATE
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 13, 85, 97 💬
40METHYLPREDNISOLONE SODIUM SUCCINATE
(D00407)		[3] Methylprednisolone,
Methylprednisolone hemisuccinate,
Succinic acid		[4] Methylprednisolone (D00407),
Methylprednisolone sodium succinate ,
Methylprednisolone acetate ,
Methylprednisolone hemisuccinate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[7] 13, 46, 49, 50, 51, 211, 222 💬
41Methylprednisolone succinate
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 66 💬
42Methylprednisolone(intravenously in the 1st-2nd-3rd month )
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
43Methylprednisolone(intravenously in the 1st-3rd-5th month)
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
44Nasal Methylprednisolone (MT)
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
45Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
46Oral Methylprednisolone 625 mg/24h x3 days
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
47Other: Exposure to methylprednisolone during pregnancy
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
48Other: IV Methylprednisolone administration
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
49Prednisone (and methylprednisolone)
(D00407)		[2] Methylprednisolone,
Prednisone		[3] Methylprednisolone (D00407),
Prednisone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
50Prednisone, methylprednisolone,cyclophosphamides
(D00407)		[2] Methylprednisolone,
Prednisone		[3] Methylprednisolone (D00407),
Prednisone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
51Preventative (Prophylactic) Medication - Corticosteroids: Methylprednisolone
(D00407)		[1] Methylprednisolone[2] Methylprednisolone (D00407),
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 2 💬
52Rituximab plus methylprednisolone
(D00407)		[2] Methylprednisolone,
Rituximab		[3] Methylprednisolone (D00407),
Methylprednisolone acetate ,
Rituximab 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63 💬
53Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)
(D00407)		[2] Methylprednisolone,
Ursodeoxycholic acid		[3] Methylprednisolone (D00407),
Ursodiol ,
Methylprednisolone acetate 💬 		[2] NR1H4,
NR3C1 💬 		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 93 💬